Table 2.
Parameters used in the economic assessment (Paton and colleagues)7
|
Cost of drugs (per dose) | |||||
|---|---|---|---|---|---|
| Drug | Average dose | Vial size (cost) | Cost per dose | ||
| Rocuronium (1.2 mg kg−1) | 90 mg | 100 mg (£6.01) | £6.01 | ||
| Succinylcholine (1 mg kg−1) | 75 mg | 100 mg (£0.71) | £0.71 | ||
| Neostigmine/glycopyrrolate | 2.5 mg/0.5 mg | 2.5/0.5 mg (£1.01) | £1.01 | ||
| Sugammadex (2 mg kg−1) | 150 mg | 200 mg (£59.64) | £59.64 | ||
| Sugammadex (4 mg kg−1) | 300 mg | 2×200 mg (£119.28) | £119.28 | ||
| Sugammadex (16 mg kg−1) | 1200 mg | 2×500 mg (£298.20) and 1×200 mg (£59.64) | £357.84 | ||
| Estimated staff costs associated with the recovery period | |||||
| Staff member | Annual salary | Annual NI and pension | Working time | Cost per minute | |
| Consultant surgeon | £117 450 | £29 686 | 41.4 weeks, 43.4 h | £1.36 | |
| SpR surgeon | £48 038 | £11 084 | 42.4 weeks, 40.0 h | £0.58 | |
| Consultant anaesthetist | £117 450 | £29 686 | 41.4 weeks, 43.4 h | £1.36 | |
| Nurse (band 5) | £22 900 | £4793 | 41.3 weeks, 37.5 h | £0.30 | |
| Nurse (band 6) | £29 200 | £6249 | 41.3 weeks, 37.5 h | £0.38 | |
| Nurse (band 7) | £34 000 | £7357 | 41.3 weeks, 37.5 h | £0.45 | |
| Weighted average | £25 075 | £5296 | £0.33 | ||
| Total | £369 038 | £88 855 | £4.44 | ||
| HRQoL index by age (adapted from Table A in Kind and colleagues)15 | Discounted, quality-adjusted life expectancy (QALYs) lost due to a fatality at age 20 and 60 yr | ||||
| Age range (yr) | Average HRQoL weight | Example age (yr) | Life expectancy (yr) | Discounted, quality-adjusted life expectancy (QALYs) | |
| 0–24 | 0.94 | 20 | 59.96 | 22.91 | |
| 25–34 | 0.93 | 60 | 22.52 | 12.33 | |
| 35–44 | 0.91 | ||||
| 45–54 | 0.85 | ||||
| 55–64 | 0.8 | ||||
| 65–74 | 0.78 | ||||
| 75+ | 0.73 | ||||